Have you ever placed a prostate cancer patient on intermittent rather than continuous androgen deprivation therapy?

Share this article:

Recent studies have looked at the use of intermittent androgen deprivation therapy (ADT) as a way to spare prostate cancer (PCa) patients some of the adverse effects associated with continuous ADT.

Study findings presented at the American Urological Association 2012 annual meeting found that intermittent ADT was associated with improved overall and PCa-specific survival in elderly men with advanced disease. But data presented at the American Society of Clinical Oncology 2012 annual meeting showed that while intermittent ADT has some quality-of-life benefits for men with metastatic PCa, overall survival times are inferior to those seen with continuous ADT.

Renal & Urology News would like to get an idea of the extent to which urologists are using intermittent ADT, so please take a few moments to answer the following question:


Leave a comment below to explain your choice.
Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Physician Polls

Do you currently accept new Medicaid patients?

Do you currently accept new Medicaid patients?

The NHS has found that 31% of physicians were unwilling to accept new Medicaid patients.

How often do you try to persuade your patients who smoke to give up the habit?

How often do you try to persuade your ...

Doctors can play an important role in educating patients who smoke about the adverse health effects.

Is allowing patients direct access to lab results a good idea?

Is allowing patients direct access to lab results ...

A ruling from the HHS took effect allowing patients direct access to medical laboratory results.